These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20723821)

  • 1. Contemporary management of patients with type 1 diabetes.
    Mehta SN; Wolfsdorf JI
    Endocrinol Metab Clin North Am; 2010 Sep; 39(3):573-93. PubMed ID: 20723821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycemia risk reduction in type 1 diabetes.
    Cryer PE
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S412-23. PubMed ID: 11460588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of new technologies in treating children and adolescents with type 1 diabetes mellitus.
    Shalitin S; Phillip M
    Pediatr Diabetes; 2007 Oct; 8 Suppl 6():72-9. PubMed ID: 17727388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing hyperglycemia from hospital admission to discharge.
    Moghissi ES
    Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A medical home for children with insulin-dependent diabetes: comanagement by primary and subspecialty physicians--convergence and divergence of opinions.
    Wegner SE; Lathren CR; Humble CG; Mayer ML; Feaganes J; Stiles AD
    Pediatrics; 2008 Aug; 122(2):e383-7. PubMed ID: 18676524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic insulin replacement in type 2 diabetes: optimizing postprandial glucose control.
    Robertson C
    Diabetes Educ; 2006; 32(3):423-32. PubMed ID: 16772658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapies for diabetes management: an update for the practicing clinician.
    Meneghini L; Hirsch IB
    Semin Thorac Cardiovasc Surg; 2006; 18(4):379-89. PubMed ID: 17395035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in the treatment of type 1 diabetes mellitus.
    Haak T
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 3():S108-13. PubMed ID: 10522818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
    Fischer JS; McLaughlin T; Loza L; Beauchamp R; Schwartz S; Kipnes M
    Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 1 diabetes mellitus: effective insulin strategies with less hypoglycemia.
    Bolli GB
    Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):13-20. PubMed ID: 19667675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Important aspects of self-management education in patients with diabetes.
    Stam DM; Graham JP
    Pharm Pract Manag Q; 1997 Jul; 17(2):12-25. PubMed ID: 10168174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on transplanting beta cells for reversing type 1 diabetes.
    Robertson RP
    Endocrinol Metab Clin North Am; 2010 Sep; 39(3):655-67. PubMed ID: 20723826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reemergence of insulin pump therapy in the 1990s.
    Reynolds LR
    South Med J; 2000 Dec; 93(12):1157-61. PubMed ID: 11142448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
    Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
    Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-monitoring of blood glucose.
    Garg S; Hirsch IB
    Int J Clin Pract Suppl; 2010 Feb; (166):1-10. PubMed ID: 20377657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulfilling the promise of insulin pump therapy in childhood diabetes.
    Tamborlane WV
    Pediatr Diabetes; 2006 Aug; 7 Suppl 4():4-10. PubMed ID: 16774611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
    Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
    Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
    Schütt M; Kern W; Krause U; Busch P; Dapp A; Grziwotz R; Mayer I; Rosenbauer J; Wagner C; Zimmermann A; Kerner W; Holl RW;
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-dependent (type I) diabetes mellitus.
    Rodger W
    CMAJ; 1991 Nov; 145(10):1227-37. PubMed ID: 1933705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing of insulin glargine in the treatment of type 2 diabetes.
    Barnett A
    Clin Ther; 2007 Jun; 29(6):987-99. PubMed ID: 17692716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.